FDA Approved: LUTATHERA — Original Application (Advanced Accelerator Applications USA, Inc)

View source ↗

Summary

The FDA approved LUTATHERA (Lutetium-177 dotatate) from Advanced Accelerator Applications USA, Inc., for adults with somatostatin receptor–positive gastroentero…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastroenteropancreatic Neuroendocrine Tumours
• Neuroendocrine Tumours

Drugs mentioned

• LUTATHERA (Lutetium Lu-177 dotatate)

Snippet

ORIG AP for LUTATHERA (LUTETIUM LU 177 DOTATATE)